The CXCL12 G801A polymorphism and cancer risk: Evidence from 17 case-control studies

Gene

Volumn 509, Issue 2, 2012, Pages 228-231

  Gong, Hua ^a   Tan, Mingyue ^a   Wang, Yong ^a   Shen, Bing ^a   Liu, Zhihong ^a   Zhang, Fang ^a   Liu, Yong ^a   Qiu, Jianxin ^a   Bao, Erdun ^a   Fan, Yu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

CXCL12; Genetic variation; Molecular epidemiology

Indexed keywords

STROMAL CELL DERIVED FACTOR 1;

ARTICLE; ASIAN; BLADDER CANCER; BREAST CANCER; CANCER RISK; CAUCASIAN; COLORECTAL CANCER; ETHNIC GROUP; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; LEUKEMIA; LIVER CELL CARCINOMA; LUNG CANCER; MOUTH CANCER; PRIORITY JOURNAL;

CASE-CONTROL STUDIES; CHEMOKINE CXCL12; GENETIC PREDISPOSITION TO DISEASE; HUMANS; META-ANALYSIS AS TOPIC; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84866434161     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.08.018     Document Type: Article

References (31)

1. Burger J.A., Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006, 107:1761-1767.
2. Chang C.C., et al. Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma. Clin. Chem. Lab. Med. 2009, 47:412-418.
3. de Oliveira C.E., et al. Stromal cell-derived factor-1 chemokine gene variant in blood donors and chronic myelogenous leukemia patients. J. Clin. Lab. Anal. 2007, 21:49-54.
4. de Oliveira K.B., et al. CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma. J. Clin. Lab. Anal. 2009, 23:387-393.
5. de Oliveira K.B., et al. CXCL12 rs1801157 polymorphism and expression in peripheral blood from breast cancer patients. Cytokine 2011, 55:260-265.
6. Dimberg J., Hugander A., Lofgren S., Wagsater D. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients. Int. J. Mol. Med. 2007, 19:11-15.
7. Fulton A.M. The chemokine receptors CXCR4 and CXCR3 in cancer. Curr. Oncol. Rep. 2009, 11:125-131.
8. Handoll H.H. Systematic reviews on rehabilitation interventions. Arch. Phys. Med. Rehabil. 2006, 87:875.
9. Hidalgo-Pascual M., et al. Analysis of CXCL12 3'UTR G>A polymorphism in colorectal cancer. Oncol. Rep. 2007, 18:1583-1587.
10. Hirata H., et al. CXCL12 G801A polymorphism is a risk factor for sporadic prostate cancer susceptibility. Clin. Cancer Res. 2007, 13:5056-5062.
11. Hirschhorn J.N., Lohmueller K., Byrne E., Hirschhorn K. A comprehensive review of genetic association studies. Genet. Med. 2002, 4:45-61.
12. Khademi B., Razmkhah M., Erfani N., Gharagozloo M., Ghaderi A. SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer. Pathol. Oncol. Res. 2008, 14:45-50.
13. Kruszyna L., et al. CXCL12-3' G801A polymorphism is not a risk factor for breast cancer. DNA Cell Biol. 2010, 29:423-427.
14. Kruszyna L., Lianeri M., Rydzanicz M., Szyfter K., Jagodzinski P.P. SDF1-3' a gene polymorphism is associated with laryngeal cancer. Pathol. Oncol. Res. 2010, 16:223-227.
15. Lee Y.L., et al. Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer. Lung Cancer 2011, 73:147-152.
16. Lin G.T., et al. Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS 2009, 13:165-172.
17. Moser B., Loetscher P. Lymphocyte traffic control by chemokines. Nat. Immunol. 2001, 2:123-128.
18. Olson K.E., Booth G.C., Poulin F., Sonenberg N., Beretta L. Impaired myelopoiesis in mice lacking the repressors of translation initiation, 4E-BP1 and 4E-BP2. Immunology 2009, 128:e376-e384.
19. Pharoah P.D., Dunning A.M., Ponder B.A., Easton D.F. Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer 2004, 4:850-860.
20. Razmkhah M., Doroudchi M., Ghayumi S.M., Erfani N., Ghaderi A. Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. Lung Cancer 2005, 49:311-315.
21. Razmkhah M., Talei A.R., Doroudchi M., Khalili-Azad T., Ghaderi A. Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Lett. 2005, 225:261-266.
22. Righi E., et al. CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. Cancer Res. 2011, 71:5522-5534.
23. Shen W., Cao X., Xi L., Deng L. CXCL12 G801A polymorphism and breast cancer risk: a meta-analysis. Mol. Biol. Rep. 2011, 39:2039-2044.
24. Teng Y.H., et al. Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer. Head Neck 2009, 31:1282-1288.
25. Thekkumkara T.J., Linas S.L. Evidence for involvement of 3'-untranslated region in determining angiotensin II receptor coupling specificity to G-protein. Biochem. J. 2003, 370:631-639.
26. Vairaktaris E., et al. A DNA polymorphism of stromal-derived factor-1 is associated with advanced stages of oral cancer. Anticancer. Res. 2008, 28:271-275.
27. Vazquez-Lavista L.G., Lima G., Gabilondo F., Llorente L. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Urology 2009, 74:414-418.
28. Watanabe M.A., et al. SDF-1 gene polymorphisms and syncytia induction in Brazilian HIV-1 infected individuals. Microb. Pathog. 2003, 35:31-34.
29. Winkler C., et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998, 279:389-393.
30. Zafiropoulos A., Crikas N., Passam A.M., Spandidos D.A. Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J. Med. Genet. 2004, 41:e59.
31. Zou Y.R., Kottmann A.H., Kuroda M., Taniuchi I., Littman D.R. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.